Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 02:18 pm EDT
Zhejiang Shengda Bio-Pharm Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 185.17 million compared to CNY 191.93 million a year ago. Revenue was CNY 185.17 million compared to CNY 191.93 million a year ago. Net income was CNY 20.8 million compared to CNY 23.39 million a year ago. Basic earnings per share from continuing operations was CNY 0.12 compared to CNY 0.14 a year ago. Diluted earnings per share from continuing operations was CNY 0.12 compared to CNY 0.14 a year ago.